Home → Products → Antibacterial → Aerocef Tazo
Antibacterial
Aerocef Tazo
Aerocef Tazo is part of the Aerovet antibacterial range. Detailed technical information is available through official Aerovet product literature and on request from our team.
Product Information
Product Name
Aerocef-Tazo
Category
3rd Generation Cephalosporin + Beta-lactamase Inhibitor
Type
Injection
Pack Size
4.5 gm vial (with WFI & 20 ml syringe needle)
Composition
Each vial contains:
• Ceftriaxone Sodium – 4000 mg
• Tazobactam Sodium – 500 mg
• Ceftriaxone Sodium – 4000 mg
• Tazobactam Sodium – 500 mg
Indications
Broad-spectrum 3rd generation antimicrobial cephalosporin combined with a beta-lactamase inhibitor. Indicated for:
• Respiratory Tract Infections – bronchitis, pneumonia, bronchopneumonia.
• Urogenital Tract Infections.
• Endometritis and bacterial septicaemia.
• Mastitis and osteoarthritis.
• Respiratory Tract Infections – bronchitis, pneumonia, bronchopneumonia.
• Urogenital Tract Infections.
• Endometritis and bacterial septicaemia.
• Mastitis and osteoarthritis.
Dosage
• Cattle & Buffalo: 5–10 mg/kg body weight, IM/IV.
• Calf, Sheep & Goat: 10–15 mg/kg body weight, IM/IV.
• Dog & Horse: 15–25 mg/kg body weight, IM/IV.
• Calf, Sheep & Goat: 10–15 mg/kg body weight, IM/IV.
• Dog & Horse: 15–25 mg/kg body weight, IM/IV.
Administration
Intramuscular (IM) / Intravenous (IV) injection.
Target Species
Cattle, buffalo, calf, sheep, goat, dog and horse.
Key Benefits
- Broad-spectrum 3rd generation cephalosporin protected against beta-lactamase resistance
- Effective against respiratory, urogenital, and reproductive tract infections
- Covers mastitis and osteoarthritis
Technical product information is published only as supplied and approved by Aerovet Life Sciences Private Limited. Please refer to official product literature and professional veterinary guidance.
More in Antibacterial
Let's Build Better
Animal Health Together
Connect with Aerovet Life Sciences for veterinary products, business enquiries and further information about our portfolio.